Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec;33(6):451-463.
doi: 10.1007/s40290-019-00305-z.

Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date

Somaya Albhaisi  1 , Arun J Sanyal  2
Affiliations
Review

Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date

Somaya Albhaisi et al. Pharmaceut Med. 2019 Dec.

Abstract

Nonalcoholic fatty liver disease (NAFLD) has now become a worldwide health issue due to the obesity epidemic, affecting approximately 90% of the obese population and 15-40% of the general population. It is the most common form of chronic liver disease in the United States. NAFLD constitutes a spectrum of diseases ranging in severity from mild, such as fatty liver, progressing into nonalcoholic steatohepatitis (NASH), then fibrosis, and ending with cirrhosis. NASH and increasing fibrosis stage are associated with increased morbidity and mortality; the fibrosis stage is therefore a critical element of risk stratification needed to determine therapeutic approach and also the response to treatment. Liver biopsy is considered the 'gold standard' in the diagnosis of NAFLD. However, it is not practical for widespread clinical use because it is invasive, costly, and associated with complications including occasional death. These limitations have driven the development of noninvasive tests that can accurately predict the fibrosis stage in those with NAFLD. In this review, we provide a concise overview of different non-invasive measurements used for NAFLD/NASH.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cell Metab. 2017 May 2;25(5):1054-1062.e5 - PubMed
    1. J Hepatol. 2006 Jun;44(6):1167-74 - PubMed
    1. Pharmacol Rev. 2008 Sep;60(3):311-57 - PubMed
    1. Curr Med Imaging Rev. 2011 Nov;7(4):255-282 - PubMed
    1. Liver Int. 2015 Feb;35(2):429-37 - PubMed

MeSH terms

LinkOut - more resources

  NODES
INTERN 4
twitter 2